Publications by authors named "N Mimura"
POEMS syndrome is a multisystemic disease associated with monoclonal plasma cell disorders. Although the presence of bone lesions is included in the diagnostic criteria, their precise manifestations remain unknown. Here, we retrospectively analyzed the bone lesions in patients with POEMS syndrome and evaluated their clinical features.
View Article and Find Full Text PDFArticle Synopsis
- The study explores how immunoadsorption plasmapheresis (IA) affects the levels of myeloid-derived suppressor cells (MDSCs), which may help in managing autoimmune diseases.
- It involved 21 patients with autoimmune neurological conditions and 8 healthy participants, measuring immune cell types and inflammatory markers before and after IA treatment.
- Results showed that IA significantly increased the number of specific MDSCs and reduced clinical symptoms in certain patients, suggesting IA may help mitigate autoimmune responses and tissue damage.
Article Synopsis
- Water intake may help prevent exercise-induced orthostatic hypotension (OH), which occurs when blood pressure drops after standing up following exercise.
- A study with 14 adults showed that those who drank 500 ml of water before exercising had a lower incidence of OH compared to those who did not drink water.
- The results also indicated that water intake improved heart rate and blood pressure responses, suggesting better cardiac function and blood pressure regulation after exercise.
Criteria for airflow obstruction (AFO) at one year after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in pulmonary function tests (PFTs) are more stringent than the bronchiolitis obliterans syndrome (BOS) criteria of the National Institutes of Health. This single-center, retrospective cohort study evaluated the clinical impact of the AFO criteria at any time after transplantation. In 132 patients who underwent allo-HSCT from 2006 to 2016, the 2-year cumulative incidence of AFO was 35.
View Article and Find Full Text PDFBackground: Prostate ductal adenocarcinoma, a rare histology observed in 0.4-0.8% of all prostate cancers, is treated similarly to acinar adenocarcinoma but tends to have a higher likelihood of metastasis, recurrence, and poorer prognosis.
View Article and Find Full Text PDF